For example, the introduction of BTG2, a tumor suppressor gene lost in metastatic lung and prostate cancers, repressed cell migration and cancer invasion by the inhibition of mitochondrial ROS as well as Src activity [38]. This evidence concerns the gene BTG2 and prostate cancer.